On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

Maxygen (United States)

InstitutionResearch output, impact & collaborations

Maxygen (United States) is a institution indexed in ScholarIQ from OpenAlex.

What is known about Maxygen (United States)?

ScholarIQrecord summary

Maxygen (United States) is a research organisation in Redwood City, US. OpenAlex records 494 works and 137,716 citations for it. 152 researchers list it as their most recent affiliation.

How many works does Maxygen (United States) have?

ScholarIQindexed works

Maxygen (United States) has 494 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Maxygen (United States) →

How many citations does Maxygen (United States) have?

ScholarIQcitation count

Maxygen (United States) has 137,716 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for Maxygen (United States) →

How many researchers are at Maxygen (United States)?

ScholarIQresearcher count

Maxygen (United States) has 152 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at Maxygen (United States)?

ScholarIQavg h-index

Maxygen (United States) has an average h-index of 44 in OpenAlex.

Open the OpenAlex record →

What is the ROR of Maxygen (United States)?

ScholarIQror

The ROR for Maxygen (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for Maxygen (United States)?

ScholarIQopenalex

The OpenAlex for Maxygen (United States) is on the source record.

Open the OpenAlex →

What is the Wikidata of Maxygen (United States)?

ScholarIQwikidata

The Wikidata for Maxygen (United States) is on the source record.

Open the Wikidata →

Who are the most-cited researchers behind Maxygen (United States)?

ScholarIQtop researchers by citations

Frederick L. Baehner · Breast Cancer Treatment Studies

252 works28,519 citations

Wei‐Chen Lee · Diabetes Management and Education

180 works28,223 citations

What are the most-cited papers on Maxygen (United States)?

ScholarIQmost cited works

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark

New England Journal of Medicine. 20046,385 CitationsOPEN ACCESS

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Roberto Salgado, Carsten Denkert, Sandra Demaria, Nicolas Sirtaine, Frederick Klauschen, Giancarlo Pruneri, Stephan Wienert, Gert Van den Eynden, Frederick L. Baehner, Frédérique Penault‐Llorca, Edith A. Perez, E. Aubrey Thompson, W. Fraser Symmans, Andrea L. Richardson, Jane Brock, Carmen Criscitiello, Helen D. Bailey, M. Ignatiadis, Giuseppe Floris, Joseph A. Sparano, Zuzana Kos, Torsten O. Nielsen, David L. Rimm, Kimberly H. Allison, Jorge S. Reis‐Filho, Sibylle Loibl, Christos Sotiriou, Giuseppe Viale, Sunil Badve, Sylvia Adams, Karen Willard‐Gallo, Sherene Loi

Annals of Oncology. 20143,175 CitationsOPEN ACCESS

Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark

Journal of Clinical Oncology. 20062,590 Citations

Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial

Kathy S. Albain, William E. Barlow, Steven Shak, Gabriel N. Hortobágyi, Robert B. Livingston, I‐Tien Yeh, Peter M. Ravdin, Roberto Bugarini, Frederick L. Baehner, Nancy E. Davidson, George W. Sledge, Eric P. Winer, Clifford A. Hudis, James N. Ingle, Edith A. Perez, Kathleen I. Pritchard, Lois E. Shepherd, Julie R. Gralow, Carl Yoshizawa, D. Craig Allred, C. Kent Osborne, Daniel F. Hayes

The Lancet Oncology. 20091,413 CitationsOPEN ACCESS

How much of the research on Maxygen (United States) is open access?

ScholarIQopen access share

75%OPEN ACCESS

Gold

Green

25%

Hybrid

Bronze

50%

Closed

25%